• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Soft drink consumption linked with increased all-cause mortality

byJames EnglandandAnees Daud
September 14, 2019
in Cardiology, Chronic Disease, Endocrinology, Gastroenterology, Public Health
Reading Time: 2 mins read
Warning labels on sugar-sweetened beverages impact parent decisions
Share on FacebookShare on Twitter

1. In this population-based cohort study, consumption of total, sugar-, and artificially-sweetened soft drinks was linked with an increased risk of all-cause mortality.

2. The consumption of artificially-sweetened soft drinks was also linked to an increase in death from circulatory diseases. Sugar-sweetened soft drinks intake was associated with death from digestive diseases.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The frequent consumption of soft drinks has been linked to an increase risk of obesity, metabolic disease including diabetes, and cardiovascular disease. The current study sought to evaluate the mortality-risk related to consumption of both artificially- and sugar-sweetened soft drinks in a population from 10 European countries. The study found that there was an increase in all-cause mortality with frequency of any soft drinks, specifically with sugar-sweetened, and artificially-sweetened soft drinks. The consumption of sugar-sweetened drinks was linked with an increase of digestive disease-related death, while artificially-sweetened soft drinks was associated with death from circulatory disease.

The study provides further evidence that population health initiatives aimed at reduction of soft drink consumption may lead to decreased morbidity and mortality. The study strengths include the long-follow up of a large, diverse European population. The main limitation is the observational design which precludes the ability to attribute causality to the observed associations.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Prognostic associations of anthropometric indices vary by clinical outcomes

2 Minute Medicine Rewind September 28, 2026

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Relevant Reading: Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta‐analysis

In-Depth [prospective cohort]: This study is a population cohort involving adults from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. This study included participants from 10 European countries: (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom. Participants were recruited between 1992 and 2000. Participants were excluded if they had a baseline history of cancer, heart disease, stroke, were in the highest or lowest 1% of energy intake, were missing data on soft drink consumption, or had missing follow-up data. Dietary information was determined using self-administered questionnaires or personal interviews.

A total of 451,743 participants were included in the study, with a median age of 50.8 years, and mean (range) follow-up of 16.4 years. Compared to non-consumers (<1 glass/month) those who consumed 2 or more glasses/day of soft drinks had higher all-cause mortality (hazard ratio [HR], 1.17; 95%CI, 1.11-1.22; P < .001). Sugar-sweetened soft drinks also had increased all cause (HR, 1.08; 95%CI, 1.01-1.16; P = .004) and digestive disease related mortality (HR, 1.59; 95%CI, 1.24-2.05; P < .001). Artificially sweetened soft drinks were linked with greater all-cause (HR, 1.26; 95%CI, 1.16-1.35; P < .001) and circulatory disease mortality (HR, 1.52; 95%CI, 1.30-1.78; P < .001)

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasedigestive diseasemortalitysugary drinks
Previous Post

#VisualAbstract: Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Next Post

#VisualAbstract: Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

RelatedReports

Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Weekly Rewinds

2 Minute Medicine Rewind September 28, 2026

September 28, 2026
Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026
Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
Next Post
#VisualAbstract: Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

#VisualAbstract: Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

Multidisciplinary approach linked with increased utilization of peritoneal dialysis for new dialysis patients

Decreased prevalence of HPV among vaccinated young females

Practitioner communication, attitudes and 2-dose schedule affect HPV vaccine administration

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training
  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.